WallStreetZenWallStreetZen

NASDAQ: DXCM
Dexcom Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for DXCM

Based on 12 analysts offering 12 month price targets for Dexcom Inc.
Min Forecast
$100.00-13.43%
Avg Forecast
$133.58+15.64%
Max Forecast
$160.00+38.5%

Should I buy or sell DXCM stock?

Based on 12 analysts offering ratings for Dexcom Inc.
Strong Buy
Strong Buy
8 analysts 66.67%
Buy
2 analysts 16.67%
Hold
2 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DXCM stock forecasts and price targets.

DXCM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-10-27
lockedlocked$00.00+00.00%2023-10-17
lockedlocked$00.00+00.00%2023-10-16
lockedlocked$00.00+00.00%2023-10-10
lockedlocked$00.00+00.00%2023-09-15
UBS
Bottom 3%
3
Strong BuyMaintains$138.00+19.46%2023-09-06
Baird
Top 13%
88
BuyMaintains$130.00+12.53%2023-08-21
Barclays
Bottom 6%
6
HoldMaintains$138.00+19.46%2023-07-31
Piper Sandler
Bottom 4%
4
Strong BuyMaintains$160.00+38.50%2023-07-28
Canaccord Genuity
Top 10%
91
Strong BuyMaintains$150.00+29.85%2023-07-28Find out why

1 of 2

Forecast return on equity

Is DXCM forecast to generate an efficient return?
Company
N/A
Industry
0%
Market
30.08%

Forecast return on assets

Is DXCM forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.01%

DXCM revenue forecast

What is DXCM's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$3.6B+5.57%
Avg 2 year Forecast
$4.2B+24.56%
Avg 3 year Forecast
$5.0B+46.88%
DXCM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DXCM earnings growth forecast

How is DXCM forecast to perform vs Medical Devices companies and vs the US market?
Company
20.58%
Industry
27.01%
Market
17.67%
DXCM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
DXCM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
DXCM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

DXCM revenue growth forecast

How is DXCM forecast to perform vs Medical Devices companies and vs the US market?
Company
13.5%
Industry
6.13%
Market
7.51%
DXCM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DXCM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DXCM vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
DXCM$115.52$133.58+15.64%Strong Buy
EW$67.71$84.21+24.37%Buy
ZBH$116.31$137.83+18.50%Buy
STE$200.94$242.60+20.73%Buy
PHG$20.42N/AN/A
View Top Medical Device Stocks

Dexcom Stock Forecast FAQ

Is Dexcom Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: DXCM) stock is to Strong Buy DXCM stock.

Out of 12 analysts, 8 (66.67%) are recommending DXCM as a Strong Buy, 2 (16.67%) are recommending DXCM as a Buy, 2 (16.67%) are recommending DXCM as a Hold, 0 (0%) are recommending DXCM as a Sell, and 0 (0%) are recommending DXCM as a Strong Sell.

If you're new to stock investing, here's how to buy Dexcom stock.

What is DXCM's revenue growth forecast for 2023-2025?

(NASDAQ: DXCM) Dexcom's forecast annual revenue growth rate of 13.5% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.13%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.51%.

Dexcom's revenue in 2023 is $3,403,000,000.On average, 10 Wall Street analysts forecast DXCM's revenue for 2023 to be $1,388,097,817,351, with the lowest DXCM revenue forecast at $1,386,178,311,642, and the highest DXCM revenue forecast at $1,390,946,166,000. On average, 10 Wall Street analysts forecast DXCM's revenue for 2024 to be $1,637,770,722,279, with the lowest DXCM revenue forecast at $1,389,902,956,376, and the highest DXCM revenue forecast at $1,728,636,985,190.

In 2025, DXCM is forecast to generate $1,931,161,065,203 in revenue, with the lowest revenue forecast at $1,653,603,167,013 and the highest revenue forecast at $2,032,095,073,739.

What is DXCM's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: DXCM) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of -0.01%.

What is DXCM's Price Target?

According to 12 Wall Street analysts that have issued a 1 year DXCM price target, the average DXCM price target is $133.58, with the highest DXCM stock price forecast at $160.00 and the lowest DXCM stock price forecast at $100.00.

On average, Wall Street analysts predict that Dexcom's share price could reach $133.58 by Oct 27, 2024. The average Dexcom stock price prediction forecasts a potential upside of 15.64% from the current DXCM share price of $115.52.

What is DXCM's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: DXCM) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.